195 related articles for article (PubMed ID: 8824515)
1. Genetic polymorphism of GSTM1, CYP2E1 and CYP2D6 in Egyptian bladder cancer patients.
Anwar WA; Abdel-Rahman SZ; El-Zein RA; Mostafa HM; Au WW
Carcinogenesis; 1996 Sep; 17(9):1923-9. PubMed ID: 8824515
[TBL] [Abstract][Full Text] [Related]
2. Polymorphism in cytochrome P450 CYP2D6, CYP1A1, CYP2E1 and glutathione S-transferase, GSTM1, GSTM3, GSTT1 and susceptibility to tobacco-related cancers: studies in upper aerodigestive tract cancers.
Matthias C; Bockmühl U; Jahnke V; Jones PW; Hayes JD; Alldersea J; Gilford J; Bailey L; Bath J; Worrall SF; Hand P; Fryer AA; Strange RC
Pharmacogenetics; 1998 Apr; 8(2):91-100. PubMed ID: 10022746
[TBL] [Abstract][Full Text] [Related]
3. Combined genetic polymorphism and risk for development of lung cancer.
el-Zein R; Zwischenberger JB; Wood TG; Abdel-Rahman SZ; Brekelbaum C; Au WW
Mutat Res; 1997 Nov; 381(2):189-200. PubMed ID: 9434875
[TBL] [Abstract][Full Text] [Related]
4. GSTM1 and GSTT1 genes are potential risk modifiers for bladder cancer.
Abdel-Rahman SZ; Anwar WA; Abdel-Aal WE; Mostafa HM; Au WW
Cancer Detect Prev; 1998; 22(2):129-38. PubMed ID: 9544433
[TBL] [Abstract][Full Text] [Related]
5. [Combined effects of genetic polymorphisms in cytochrome P450s and GSTM1 on lung cancer susceptibility].
Gu YF; Zhang ZD; Zhang SC; Zheng SH; Jia HY; Gu SX
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(43):3064-8. PubMed ID: 18261353
[TBL] [Abstract][Full Text] [Related]
6. Association of genetic polymorphism of glutathione S-transferase (GSTM1, GSTT1, GSTP1) with bladder cancer susceptibility.
Safarinejad MR; Safarinejad S; Shafiei N; Safarinejad S
Urol Oncol; 2013 Oct; 31(7):1193-203. PubMed ID: 22154357
[TBL] [Abstract][Full Text] [Related]
7. GSTA1, GSTM1, GSTP1, and GSTT1 polymorphisms and susceptibility to smoking-related bladder cancer: a case-control study.
Matic M; Pekmezovic T; Djukic T; Mimic-Oka J; Dragicevic D; Krivic B; Suvakov S; Savic-Radojevic A; Pljesa-Ercegovac M; Tulic C; Coric V; Simic T
Urol Oncol; 2013 Oct; 31(7):1184-92. PubMed ID: 24075358
[TBL] [Abstract][Full Text] [Related]
8. Role of CYP2D6, CYP1A1, CYP2E1, GSTT1, and GSTM1 genes in the susceptibility to acute leukemias.
Aydin-Sayitoglu M; Hatirnaz O; Erensoy N; Ozbek U
Am J Hematol; 2006 Mar; 81(3):162-70. PubMed ID: 16493615
[TBL] [Abstract][Full Text] [Related]
9. Genetic polymorphisms of CYP2D6, GSTM1, and GSTT1 genes and bladder cancer risk in North India.
Sobti RC; Al-Badran AI; Sharma S; Sharma SK; Krishan A; Mohan H
Cancer Genet Cytogenet; 2005 Jan; 156(1):68-73. PubMed ID: 15588859
[TBL] [Abstract][Full Text] [Related]
10. Genetic polymorphism of glutathione S-transferases M1 and T1 as a risk factor in lung and bladder cancers.
Salagovic J; Kalina I; Stubna J; Habalová V; Hrivnák M; Valanský L; Kohút A; Biros E
Neoplasma; 1998; 45(5):312-7. PubMed ID: 9921921
[TBL] [Abstract][Full Text] [Related]
11. Genetic variants of the cytochrome P450 and glutathione S-transferase associated with risk of bladder cancer in a south-eastern Chinese population.
Shao J; Gu M; Zhang Z; Xu Z; Hu Q; Qian L
Int J Urol; 2008 Mar; 15(3):216-21. PubMed ID: 18304215
[TBL] [Abstract][Full Text] [Related]
12. The CYP2D6 extensive metabolizer genotype is associated with increased risk for bladder cancer.
Abdel-Rahman SZ; Anwar WA; Abdel-Aal WE; Ghoneim MA; Au WW
Cancer Lett; 1997 Oct; 119(1):115-22. PubMed ID: 18372530
[TBL] [Abstract][Full Text] [Related]
13. Polymorphisms of the GSTM1 and CYP2D6 genes associated with susceptibility to lung cancer in Chinese.
Gao Y; Zhang Q
Mutat Res; 1999 Aug; 444(2):441-9. PubMed ID: 10521684
[TBL] [Abstract][Full Text] [Related]
14. Genetic polymorphisms of CYP2E1 and GSTM1 in a Thai population.
Sangrajrang S; Jedpiyawongse A; Srivatanakul P
Asian Pac J Cancer Prev; 2006; 7(3):415-9. PubMed ID: 17059334
[TBL] [Abstract][Full Text] [Related]
15. Genetic polymorphism of drug metabolizing enzymes (CYP2E1, GSTP1) and susceptibility to bladder cancer in North India.
Mittal RD; Srivastava DS; A M; B M
Asian Pac J Cancer Prev; 2005; 6(1):6-9. PubMed ID: 15780023
[TBL] [Abstract][Full Text] [Related]
16. Susceptibility to multiple cutaneous basal cell carcinomas: significant interactions between glutathione S-transferase GSTM1 genotypes, skin type and male gender.
Heagerty A; Smith A; English J; Lear J; Perkins W; Bowers B; Jones P; Gilford J; Alldersea J; Fryer A; Strange RC
Br J Cancer; 1996 Jan; 73(1):44-8. PubMed ID: 8554981
[TBL] [Abstract][Full Text] [Related]
17. Relationship between genetic polymorphisms of metabolizing enzymes CYP2E1, GSTM1 and Kazakh's esophageal squamous cell cancer in Xinjiang, China.
Lu XM; Zhang YM; Lin RY; Arzi G; Wang X; Zhang YL; Zhang Y; Wang Y; Wen H
World J Gastroenterol; 2005 Jun; 11(24):3651-4. PubMed ID: 15968714
[TBL] [Abstract][Full Text] [Related]
18. Polymorphism of metabolizing genes and lung cancer histology: prevalence of CYP2E1 in adenocarcinoma.
El-Zein RA; Zwischenberger JB; Abdel-Rahman SZ; Sankar AB; Au WW
Cancer Lett; 1997 Jan; 112(1):71-8. PubMed ID: 9029171
[TBL] [Abstract][Full Text] [Related]
19. Cytochrome P450 2D6 and glutathione S-transferase M1 genotypes and migraine.
Mattsson P; Bjelfman C; Lundberg PO; Rane A
Eur J Clin Invest; 2000 Apr; 30(4):367-71. PubMed ID: 10759887
[TBL] [Abstract][Full Text] [Related]
20. CYP1A2, CYP2D6, GSTM1, GSTP1, and GSTT1 gene polymorphisms in patients with bladder cancer in a Turkish population.
Altayli E; Gunes S; Yilmaz AF; Goktas S; Bek Y
Int Urol Nephrol; 2009; 41(2):259-66. PubMed ID: 18690546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
